Skip to Content

FDA Approves Lecanemab for Treatment of Early Alzheimer’s Disease

FDA has given full accelerated approval of lecanemab for treatment of early Alzheimer’s Disease.

Get access

If you are a doctor or other health professional, you can access the entire article by creating a profile on BestPractice Nordic.

Back to top